GALVmed aims to make a significant contribution towards transformational change in the smallholder livestock health landscape by developing a portfolio of high impact products and initiating a range of private sector market initiatives operating at scale in the smallholder sector.
About GALVmed
Foot and Mouth Disease is a highly contagious livestock disease. Morbidity levels can reach 100%
International and regional trade of animals and animal products are compromised and disrupted, leading to severe socio-economic consequences
Vaccination is proven to effectively control FMD
The FMD Project encourages the development of a private sector model for buying and distributing high-quality FMD vaccines
Product development
GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.
Policy and advocacy
The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.
The AgResults Foot and Mouth Disease (FMD) Vaccine Challenge Project is an eight-year, US$15.8 million prize competition that supports the development and uptake of high-quality FMD vaccines tailored to meet the needs of Eastern …
45-year-old Paul Mathai looks forlornly at his nearly empty cow shed. A few months ago, all the nine paddocks were occupied. Today, only three of his dairy cows are left. And he has no calves …
Our professional lives are often so cramped with problems to solve, targets to reach and deadlines to meet that we may find it difficult to think. However, it is when we stop and make time …
